Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial.

ABSTRACT:

Objectives

C-reactive protein point-of-care testing (CRP POCT) is a promising diagnostic tool to guide antibiotic prescribing for lower respiratory tract infections (LRTI) in nursing home residents. This study aimed to evaluate cost-effectiveness and return-on-investment (ROI) of CRP POCT compared with usual care for nursing home residents with suspected LRTI from a healthcare perspective.

Design

Economic evaluation alongside a cluster randomised, controlled trial.

Setting

11 Dutch nursing homes.

Participants

241 nursing home residents with a newly suspected LRTI.

Intervention

Nursing home access to CRP POCT (POCT-guided care) was compared with usual care without CRP POCT (usual care).

Main outcome measures

The primary outcome measure for the cost

SUBMITTER: Boere TM 

PROVIDER: S-EPMC9478864 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature